Trivalent, bispecific antibodies

US11993642B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Ulrich Brinkmann · Weilheim, DE
• Rebecca Croasdale · Antdorf, DE
• Eike Hoffmann · Viernheim, DE
• Christian Klein · Iffeldorf, DE
• Ekkehard Moessner · Kreuzlingen, CH
• Juergen Michael Schanzer · Traunstein, DE
• Claudio Sustmann · Munich, DE
• Pablo Umana · Wollerau, CH

Key dates

• Filing date: May 15, 2019
• Grant date: May 28, 2024
• Expiry date: Jul 9, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/00
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention relates to trivalent, bispecific antibodies, methods for their production, pharmaceutical compositions containing the antibodies, and uses thereof.